Skip to main content
H.R. 5052 114th Congress House

OPEN Act

Official title: To direct the Attorney General and the Secretary of Health and Human Services to evaluate the effectiveness of grant programs that provide grants for the prima… Show full official titleShow less

Official title: To direct the Attorney General and the Secretary of Health and Human Services to evaluate the effectiveness of grant programs that provide grants for the primary purpose of providing assistance in addressing problems pertaining to opioid abuse, and for other purposes.

Introduced: April 26, 2016 See on congress.gov
Crime and Law Enforcement Drug trafficking and controlled substancesDrug, alcohol, tobacco useGovernment studies and investigationsHealth programs administration and funding
More subjectsShow fewer subjects
Law enforcement administration and fundingPerformance measurement
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 17 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 11, 2016
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
May 10, 2016
Motion to reconsider laid on the table Agreed to without objection.
May 10, 2016
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 1 (Roll no. 181). (text: CR H2181-2182)
May 10, 2016
Considered as unfinished business. (consideration: CR H2193-2194)
May 10, 2016
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
May 10, 2016
DEBATE - The House proceeded with forty minutes of debate on H.R. 5052.
May 10, 2016
Considered under suspension of the rules. (consideration: CR H2181-2184)
May 10, 2016
Mr. Goodlatte moved to suspend the rules and pass the bill, as amended.
May 6, 2016
Placed on the Union Calendar, Calendar No. 417.
May 6, 2016
Committee on Energy and Commerce discharged.
May 6, 2016
Reported by the Committee on Judiciary. H. Rept. 114-541, Part I.
Apr 29, 2016
Referred to the Subcommittee on Health.
Apr 28, 2016
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Apr 27, 2016
Ordered to be Reported by Voice Vote.
Apr 27, 2016
Committee Consideration and Mark-up Session Held.
Apr 26, 2016
Introduced in House
Apr 26, 2016
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
May 10, 2016 House · vote #181 On Motion to Suspend the Rules and Pass, as Amended Passed 410–1 See who voted →
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 11, 2016

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

 Plain-English summary Congressional Research Service

Opioid Program Evaluation Act or the OPEN Act

(Sec. 2) This bill directs the Department of Justice (DOJ) to enter into an arrangement with the National Academy of Sciences (NAS) to identify outcomes and develop metrics to evaluate: (1) the incidence of opioid abuse and illegal opioid distribution, and (2) the effectiveness of a DOJ grant program to provide opioid abuse services.

DOJ must publish outcomes and metrics and require grant recipients to collect and report data. The NAS must publish the evaluations.

(Sec. 3) Additionally, the bill directs the Department of Health and Human Services (HHS) to enter into an arrangement with the NAS to identify outcomes and develop metrics to evaluate: (1) the incidence of opioid abuse and illegal opioid distribution, and (2) the effectiveness of HHS grant programs to address opioid abuse.

HHS must publish outcomes and metrics and require grant recipients to collect and report data. The NAS must publish the evaluations.

(Sec. 6) It amends the Justice Assistance Act of 1984 to reduce for FY2022 the authorization of appropriation for financial assistance under the Emergency Federal Law Enforcement Assistance program.

 Related & companion bills 2
  • HR 5189 Opioid Abuse Crisis Act of 2016
  • S 524 Comprehensive Addiction and Recovery Act of 2016
 Bill text 4 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 1
All 1 Democratic 1
D
Hoyer, Steny H.
Maryland · Apr 26, 2016
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5052: OPEN Act. 114th Congress. Open America. https://openamerica.io/bill/114-HR-5052/
MLA
"H.R. 5052: OPEN Act." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-5052/.
Bluebook (legal)
H.R. 5052, 114th Cong. (2026), https://openamerica.io/bill/114-HR-5052/.
Markdown link
[H.R. 5052: OPEN Act](https://openamerica.io/bill/114-HR-5052/)
Report a problem